News | March 13, 2024
Evonik establishes a new research institute dedicated to skin sciences
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
It is the first autotaxin inhibitor to be investigated in cancer patients
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU
Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
The initiation of the second clinical trial in the INTerpath program represents rapid expansion in research for additional tumor types for individualized neoantigen therapy, V940 (mRNA-4157)
Subscribe To Our Newsletter & Stay Updated
